Suppr超能文献

抗人IgG同种型单克隆抗体的制备及特性

Production and properties of monoclonal antibodies against human IgG isotypes.

作者信息

Hasnaoui M, Blanchard D, Willem C, Loirat M J, Lambin P

机构信息

Institut National de la Transfusion Sanguine, Paris, France.

出版信息

Hybridoma. 1996 Oct;15(5):351-8. doi: 10.1089/hyb.1996.15.351.

Abstract

Several monoclonal antibodies (MAbs) against human IgG isotypes were obtained by the fusion of myeloma cells with splenocytes from mice immunized with IgG fractions extracted from human plasma. Four MAbs (F7H7, D4F8, B12A8, and E7E10) were selected by an ELISA technique on the basis of their ability to detect one of the four IgG subclasses. Their specificity was checked using a panel of pure myeloma proteins representative of the main allotypes present on IgG isotypes. In addition, two other MAbs (F3E12 and E6D6) were found able to detect specifically kappa or lambda light chains. The immunochemical properties of these MAbs were analyzed mainly in respect to their capacity to detect and to purify the different human IgG isotypes. The following data were obtained: (1) The ability of the MAbs F7H7, D4F8, B12A8, and E7E10 to measure the concentration of each IgG subclass in serum was estimated by an immunocapture ELISA. Results obtained with the new antibodies were compared with several other MAbs recommended by the IUIS/WHO human Immunoglobulins subcommittee. Similar or better results were obtained with the new anti-IgG1, anti-IgG3, and anti-IgG4, MAbs. (2) The same MAbs were tested for their ability to purify a single IgG subclass from IgG preparations and from normal and pathological sera. Fractions containing about 80% of purified IgG1, IgG3, and IgG4 were obtained after one-step immunoaffinity purification. Consequently, these MAbs proved to be useful to detect, to measure and to purify IgG subclasses.

摘要

通过将骨髓瘤细胞与用从人血浆中提取的IgG组分免疫的小鼠脾细胞融合,获得了几种抗人IgG同种型的单克隆抗体(MAb)。基于它们检测四种IgG亚类之一的能力,通过ELISA技术选择了四种MAb(F7H7、D4F8、B12A8和E7E10)。使用一组代表IgG同种型上存在的主要同种异型的纯骨髓瘤蛋白检查它们的特异性。此外,发现另外两种MAb(F3E12和E6D6)能够特异性检测κ或λ轻链。主要就这些MAb检测和纯化不同人IgG同种型的能力分析了它们的免疫化学性质。获得了以下数据:(1)通过免疫捕获ELISA评估MAb F7H7、D4F8、B12A8和E7E10测量血清中每种IgG亚类浓度的能力。将用新抗体获得的结果与IUIS/WHO人类免疫球蛋白小组委员会推荐的其他几种MAb进行比较。用新的抗IgG1、抗IgG3和抗IgG4 MAb获得了相似或更好的结果。(2)测试了相同的MAb从IgG制剂以及正常和病理血清中纯化单一IgG亚类的能力。经过一步免疫亲和纯化后,获得了含有约80%纯化IgG1、IgG3和IgG4的级分。因此,这些MAb被证明可用于检测、测量和纯化IgG亚类。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验